MyOme

MyOme’s Proactive Health uses whole genome sequencing to offer integrated risk assessments for 200+ conditions. Empowering personalized prevention like never before. 🔗 Learn more: myome.com #ProactiveHealth #IntegratedRisk #DiseasePrevention

MyOme is at #PM2025! Find us at Booth #11 today and tomorrow to: 🔬 See how we're using whole genome sequencing to transform preventive medicine. 💡 Learn how our approach to precision genomics is reshaping personalized care. Let’s connect! #PreventativeMedicine #GeneticTesting

To the incredible teams at @NateraGenetics and @myomeinc: Your tireless and brilliant work is shaping the future of healthcare in the US and beyond. Thank you. #EmployeeAppreciationDay

No family should be denied life-changing genetic insights because of financial barriers. That’s why we created MyOme Access, our financial assistance program to make rare disease genetic testing more affordable. Learn more and apply: myome.com/access

Excited to be announce our Rare Disease Diagnostic Portfolio—powered by whole genome sequencing to transform rare disease testing. Learn more: lnkd.in/gKcXcTze

Join us at #ACMG2025 We will be showcasing our upcoming rare disease products in our showcase, Advancing Rare Disease Diagnostics, on March 19th at 12:15 PM PST. Lunch will be provided. Register here: lnkd.in/gP847QVR

Our next roundtable covers the challenges & strategies for integrating vast, multi-modal datasets into #diagnostics organizations clinical testing workflows. hubs.ly/Q0357tQq0 @DCGenomics @premal2000 @myomeinc @myriadgenetics @Labcorp

Heart disease is still the biggest killer, more than all cancers combined. 47% of adults are at risk for heart disease and we can do far better than the current metrics based on clinical data. @MyOmeInc's CAD iPRS changes everything. Data-driven risk detection = huge cost…

Today we are excited to launch CAD iPRS — a cutting-edge, genome-wide polygenic risk score for coronary artery disease. Empowering primary care to identify high-risk patients and personalize prevention strategies. Read more here: prnewswire.com/news-releases/…

This is deeply personal for me. The MyOme team launched our Coronary Artery Disease (CAD) integrated PRS (iPRS) today with immediate availability. All PRS scores and reports are the not the same. We integrate relevant clinical factors—those you collect routinely during your…

💡 Could preventive genomic medicine save $200 billion in healthcare costs? @myomeinc co-founder @MattRVerse explains how tools like whole #genomesequencing & #polygenicriskscores are shifting #medicine from reactive to proactive. 🎧 DNA Today Ep. 329: dnapodcast.com/episodes/2025/…

We’ve gathered an expert panel to discuss clinical testing innovations & how #diagnostics orgs can bridge the gap between research, #drugdevelopment, healthcare providers & patients. hubs.ly/Q036jg3q0 @DCGenomics @premal2000 @myomeinc @myriadgenetics @Labcorp

Looking forward to sharing the great work of the @myomeinc team. This is an exciting time in genomics and will discuss how make it less intimidating and applicable to all.

MyOme’s Dr. Akash Kumar will speak at WashU Medicine’s Rare Disease Day event on: 📅 Feb 20 | 1:45PM PT / 3:45PM CT 🧬 Shortening Diagnostic Timelines for Rare Diseases – A Whole-Genome Platform Approach

Congratulations to our executive chairman and co-founder @MattRVerse, who was celebrated yesterday as a Luminary Honoree at the @PMWCintl - Precision Medicine World Conference. In accepting his award, Matt delivered a keynote presentation to a packed room entitled "The Power of a…

Our next roundtable explores challenges in clinical testing for #oncology & #raredisease including how to integrate & analyze multi-modal datasets. hubs.ly/Q0357s9s0 @DCGenomics @premal2000 @myomeinc @myriadgenetics @Labcorp

Our chairman, @MattRVerse, will be giving the Keynote Speech titled "The Power of a Blood Sample" at #PMWC25 this Thursday, February 6th at 4:30 PM.

We're partnering with Novi Health to bring whole genome testing to employer health programs! Employees and their families can access single-gene risk, PGx reports, integrated risk (PRS) reports, and expert genetic counseling. Read more in our PR here: prnewswire.com/news-releases/…

Premal S. Shah, PhD, CEO is excited to speak at #PMWC2025 on Feb 6 at 2 PM. We'll discuss integrated polygenic risk scores for breast cancer & coronary artery disease. Learn more: pmwcintl.com/program/ #PrecisionMedicine

Natera, MyOme Partner to Launch Cross-Ancestry, Integrated Breast Cancer Polygenic Risk Score genomeweb.com/molecular-diag…

Our new initiative, Catalyst, continues to focus on improving health outcomes. Our partnerships with MyOme & Broad Clinical Labs allow us to work together to provide patients with free genome sequencing, polygenic risk scores, & improved healthcare access: southernresearch.org/myome-and-broa…